Our lab uses the C-Chamber Incubator Subchamber System and ProOx C21 O2/CO2 controller from BioSpherix to control physiologically relevant oxygen level in our stem cell & tissue engineering experiments with organoids and 3D cultures. Learn more:https://biospherix.com/tissue-engineering/
Explosive progress in human induced stem cells (hiPSCs) has provided great opportunities for precision medicine and companion diagnostics on patient-derived cells with increasing ease. The research of my lab integrates hiPSC biology, tissue engineering and gene editing technologies to lead the development of next generation hiPSC-based patient/disease-specific in vitro tissue models and organ-on-chip systems. These tissue models aim to accurately recapitulate the complexity of three-dimensional (3D) tissue architecture, the dynamics of in vivo-like biological response, and pathophysiological status of human tissue for better understanding human disease etiology and evaluating the efficacy of the personalized treatments to the individual patients, moving human healthcare into the era of precision medicine.